INTRON A (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the INTRON A drug offered from Merck Sharp & Dohme Corp.. This Interferon Alfa-2b [Chemical/Ingredient],Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: Interferon alfa-2b
SUBSTANCE NAME: INTERFERON ALFA-2B
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Interferon Alfa-2b [Chemical/Ingredient],Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient]
ROUTE: INTRALESIONAL; INTRAMUSCULAR; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1986-06-04
END MARKETING DATE: 0000-00-00


INTRON A HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINTRON A from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 19.2(ug/.5mL)
START MARKETING DATE: 1986-06-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0085-1133_14fa9d3f-4a12-4259-b2b7-217f1d1c7328
PRODUCT NDC: 0085-1133
APPLICATION NUMBER: BLA103132

Other INTERFERON ALFA-2B Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.INTRON A